Colorectal Cancer Screening Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Colorectal Cancer Screening Tests Pipeline Market Report Overview
Colorectal cancer screening tests are carried out to monitor the bowel health of at-risk individuals, typically the elderly, to be able to detect and treat colorectal cancer in time.
The Colorectal Cancer Screening Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Segments | · Other Colorectal Cancer Screening Tests
· Fecal DNA Test Kits · Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits |
| Key Territories | · The US
· Europe · India · Israel · Canada |
| Key Regulatory Paths | · 510(k)
· CE-IVD · NMPA · PMA · HSA |
| Leading Companies | · Acuamark Diagnostics Inc.
· Advanced Marker Discovery SL · Anixa Diagnostics Corporation · Arbele Corp · Augusta University |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Buy the Full Report for More Insights into the Colorectal Cancer Screening Tests Pipeline Market
Colorectal Cancer Screening Tests Pipeline Market Segments
The key segments in the colorectal cancer screening tests pipeline market are other colorectal cancer screening tests, fecal DNA tests, and immunochemical fecal occult blood test (iFOBT or FIT) Kits. Other colorectal cancer screening tests had the highest number of pipeline products in the colorectal cancer screening tests pipeline market as of October 2024.
Colorectal Cancer Screening Tests Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segment Insights into the Colorectal Cancer Screening Tests Pipeline Market
Colorectal Cancer Screening Tests Pipeline Market Segmentation by Territories
The United States (US), Europe, India, Israel, and Canada among others are a few of the key territories of the colorectal cancer screening tests pipeline market. As of October 2024, the US accounted for the highest number of pipeline products.
Colorectal Cancer Screening Tests Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Colorectal Cancer Screening Tests Pipeline Market
Colorectal Cancer Screening Tests Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the colorectal cancer screening tests pipeline products market are 510(k), CE-IVD, NMPA, PMA, and HSA. As of October 2024, 510(k) is the most followed pathway for pipeline products in the colorectal cancer screening tests market.
Colorectal Cancer Screening Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Colorectal Cancer Screening Tests Pipeline Market
Colorectal Cancer Screening Tests Pipeline Market – Competitive Landscape
A few of the key companies associated with the colorectal cancer screening tests pipeline market are Acuamark Diagnostics Inc., Advanced Marker Discovery SL, Anixa Diagnostics Corporation, Arbele Corp, and Augusta University, among others.
Acuamark Diagnostics Inc: Acuamark Diagnostics, Inc. (formerly iCareDx, Inc.), is engaged in developing technologies for blood-based screening and early detection of cancer. The company is headquartered in the US.
Advanced Marker Discovery SL: Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company provides test products and diagnostic tools for lung cancer, colon cancer, and prostate cancer. It offers diagnostic tools that support the physician’s decisions about patient management. Amadix provides discovery, clinical validation, assay development, clinical utility, commercialization, in-licensing, and out-licensing services.
Colorectal Cancer Screening Tests Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Colorectal Cancer Screening Tests Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Colorectal Cancer Screening Tests Pipeline Market Segments Outlook (2024)
- Other Colorectal Cancer Screening Tests
- Fecal DNA Test Kits
- Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits
Colorectal Cancer Screening Tests Pipeline Market Territories Outlook (2024)
- The United States
- Europe
- India
- Israel
- Canada
Colorectal Cancer Screening Tests Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE-IVD
- NMPA
- PMA
- HSA
Scope
This report provides:
- Extensive coverage of the colorectal cancer screening tests under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- The major players involved in the development of colorectal cancer screening tests and lists all their pipeline projects.
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of colorectal cancer screening tests under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Analyze the product’s current stage of development, territory, and estimated launch date.
Advanced Marker Discovery SL
Anixa Diagnostics Corporation
Arbele Corp
Augusta University
Bar Harbor BioTechnology Inc (Inactive)
Beacon Biomedical Inc
Beckman Research Institute Of The City Of Hope
Beijing Youxun Medical Laboratory Co Ltd
BGI Genomics Co Ltd
Biocept Inc
Biome Diagnostics GmbH
Castle Biosciences Inc
CellMax Life Inc
Celtic Medical BV
CRC Bioscreen
Creative Biosciences (Guangzhou) Co Ltd
Curo Biosciences Pvt Ltd
Diagen
DiagNodus Ltd
EHang (Suzhou) Biomedical Co Ltd
Epigenomics Inc
Exact Sciences Corp
Faknostics LLC
Foundation Medicine Inc
G Medical Health and Wellness
Geneoscopy LLC
Genetic Technologies Ltd
Genetron Health (Beijing) Co Ltd
Genoptix Inc (Inactive)
Guardant Health Inc
Hangzhou Heyi Gene Technology Co Ltd
Human Metabolome Technologies Inc
iCellate Medical AB
Interpace Biosciences Inc
JL Medi Labs Co Ltd
Mainz Biomed NV
mBioSys Pvt Ltd
Neuome Peptides Pte Ltd
New Day Diagnostics LLC
Nucleix Ltd
Ohio State University
Oncodiag
Oncomark Ltd
Ourotech Ltd
Prenetics Ltd
Preora Healthcare Inc
QuantuMDx Group Ltd
Rarity Bioscience AB
Rhythm Biosciences Ltd
Shanghai Singlera Genomics Technologies Co Ltd
Shenzhen Youshengkang Biotechnology Co., Ltd.
Singlera Genomics Inc
Surfix BV
The Chinese University of Hong Kong
Thermo Fisher Scientific Inc
University of Helsinki
University of Oxford
Vastcon Inc
VolitionRX Ltd
Zhongjing Pukang (Beijing) Pharmaceutical Technology Co., Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the colorectal cancer screening tests pipeline market as of October 2024?
As of October 2024, the US accounted for the highest number of pipeline products in the colorectal cancer screening tests market.
-
Which was the most followed regulatory pathway in the colorectal cancer screening tests pipeline market as of October 2024?
As of October 2024, 510(k) was the most followed pathway for pipeline products in the colorectal cancer screening tests market.
-
Which are the major companies operating in the colorectal cancer screening tests pipeline market?
A few of the key companies associated with the colorectal cancer screening tests pipeline market are Acuamark Diagnostics Inc., Advanced Marker Discovery SL, Anixa Diagnostics Corporation, Arbele Corp, and Augusta University, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Colorectal Cancer Screening Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
